These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1149 related items for PubMed ID: 24001413

  • 1. Vitiligo: is it grace or curse?
    Bakry OA, Hammam MA, Abdel Wahed MM.
    Acta Dermatovenerol Croat; 2013; 21(2):71-9. PubMed ID: 24001413
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased epidermal functioning wild-type p53 expression in vitiligo.
    Schallreuter KU, Behrens-Williams S, Khaliq TP, Picksley SM, Peters EM, Marles LK, Westerhof W, Miehe B, Fanghänel J.
    Exp Dermatol; 2003 Jun; 12(3):268-77. PubMed ID: 12823440
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed caucasian patients with vitiligo.
    Schallreuter KU, Tobin DJ, Panske A.
    Dermatology; 2002 Jun; 204(3):194-201. PubMed ID: 12037447
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
    Seleit I, Bakry OA, Abdou AG, Dawoud NM.
    Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
    [Abstract] [Full Text] [Related]

  • 8. Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study.
    Attwa E, Gamil H, Assaf M, Ghonemy S.
    Arch Dermatol Res; 2012 Dec; 304(10):823-30. PubMed ID: 22832941
    [Abstract] [Full Text] [Related]

  • 9. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG, Maraee AH, Shoeib MA, Elbana R.
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Eumelanin and phaeomelanin contents of depigmented and repigmented skin in vitiligo patients.
    Parsad D, Wakamatsu K, Kanwar AJ, Kumar B, Ito S.
    Br J Dermatol; 2003 Sep; 149(3):624-6. PubMed ID: 14510999
    [Abstract] [Full Text] [Related]

  • 12. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ, Swanson NN, Pittelkow MR, Peters EM, Schallreuter KU.
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [Abstract] [Full Text] [Related]

  • 13. The role of p53 in pigmentation, tanning and melanoma.
    Box NF, Terzian T.
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):525-33. PubMed ID: 18761658
    [Abstract] [Full Text] [Related]

  • 14. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
    El-Darouti MA, Marzouk SA, Azzam O, Fawzi MM, Abdel-Halim MR, Zayed AA, Leheta TM.
    Eur J Dermatol; 2006 Oct; 16(1):17-22. PubMed ID: 16436337
    [Abstract] [Full Text] [Related]

  • 15. A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.
    Nan H, Qureshi AA, Hunter DJ, Han J.
    Cancer Causes Control; 2009 Mar; 20(2):171-9. PubMed ID: 18814047
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical expression of heat shock protein 70 in vitiligo.
    Abdou AG, Maraee AH, Reyad W.
    Ann Diagn Pathol; 2013 Jun; 17(3):245-9. PubMed ID: 23352325
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.